Oxurion NV (EBR:OXUR)

Belgium flag Belgium · Delayed Price · Currency is EUR
0.0570
+0.0020 (3.64%)
May 27, 2025, 3:25 PM CET
-94.30%
Market Cap 338.58K
Revenue (ttm) 3.00K
Net Income (ttm) 119.00K
Shares Out 6.16M
EPS (ttm) 0.09
PE Ratio 0.59
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 55,343
Average Volume 95,973
Open 0.0550
Previous Close 0.0550
Day's Range 0.0550 - 0.0570
52-Week Range 0.0480 - 2.0000
Beta 0.70
RSI 24.02
Earnings Date May 19, 2025

About Oxurion NV

Oxurion NV, a biopharmaceutical company, develops medicines to prevent blindness in Belgium. The company is developing ophthalmic treatments to preserve vision for patients with retinal disorders, including geographic atrophy and age-related macular degeneration. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1991
Employees 11
Stock Exchange Euronext Brussels
Ticker Symbol OXUR
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.